Workup for Elevated Iron Studies
When you encounter elevated serum iron, ferritin, and transferrin saturation, immediately measure both serum ferritin and transferrin saturation as your first step, then proceed to HFE genetic testing (specifically C282Y mutation) if transferrin saturation is >45% in females or >50% in males with ferritin >200 µg/L in females or >300 µg/L in males. 1
Initial Laboratory Assessment
The 2022 EASL guidelines provide the most current framework with 100% consensus on the diagnostic approach 1:
- Measure transferrin saturation and serum ferritin together - this is the mandatory first step
- Add serum iron and total iron binding capacity (TIBC) or transferrin for additional differential diagnosis information (87% consensus)
- Do NOT measure hepcidin - this is not recommended (100% consensus) 1
Key thresholds for proceeding to genetic testing in European populations:
- Females: Transferrin saturation >45% AND ferritin >200 µg/L
- Males: Transferrin saturation >50% AND ferritin >300 µg/L
- OR persistently elevated transferrin saturation without clear explanation 1
Genetic Testing Strategy
Order HFE genotyping for C282Y mutation when biochemical thresholds are met 1. This has 100% consensus support and should be done after obtaining informed consent for genetic testing.
The transferrin saturation is the pivotal discriminating test - it distinguishes true iron overload from other causes of hyperferritinemia 2. Most cases of elevated ferritin do NOT have iron overload 3.
Important Caveats About Ferritin
Ferritin is an acute phase reactant and can be elevated due to:
- Inflammation or infection
- Malignancy
- Liver disease
- Renal disease
- Metabolic syndrome
- Alcohol consumption
These are the most common causes of secondary hyperferritinemia 2. Therefore, ferritin alone is insufficient - you must evaluate transferrin saturation to determine if true iron overload exists 1, 4.
Advanced Imaging When Diagnosis Unclear
Use MRI with R2 sequences to quantify hepatic iron concentration* when 1:
- Cause of hyperferritinemia remains unclear after initial workup
- Biochemical iron overload is present but genetic testing is negative or shows compound heterozygosity
- Positive liver iron staining on biopsy
- Need to assess extrahepatic organ involvement
MRI is particularly valuable because serum parameters alone are often insufficient to confirm tissue iron overload 1. The distribution pattern helps differentiate causes:
- Predominant hepatic iron with minimal splenic iron → hemochromatosis or aceruloplasminemia
- Increased splenic iron → ferroportin disease or transfusional overload 1
Cardiac MRI should be performed if there are signs of heart disease or in juvenile hemochromatosis 1.
Liver Biopsy Considerations
Perform liver biopsy to assess fibrosis if 1:
- Serum ferritin >1,000 µg/L, OR
- Liver enzymes are elevated
Do NOT perform liver biopsy for diagnosis of iron overload itself - MRI is superior for this purpose 1. Biopsy is reserved for assessing degree of liver damage, not confirming iron overload.
Special Populations and Genetic Variants
If C282Y homozygosity is not found but iron overload is confirmed:
Investigate for additional causes including 1:
- Alcohol consumption (most common secondary cause)
- Metabolic syndrome (very common secondary cause)
- Other genetic variants (H63D compound heterozygosity or homozygosity)
- Rare forms of iron overload requiring referral to specialized centers
For H63D variants: Management is guided by phenotype, not genotype alone (100% consensus) 1. These patients need evaluation for additional environmental risk factors if iron overload is present.
Family Screening
Test first-degree adult relatives (>18 years) of C282Y homozygous patients with HFE genetic testing after informed consent 1. This has 100% consensus support.
Monitoring Strategy
If initial evaluation shows elevated ferritin but transferrin saturation is normal or only mildly elevated:
- Monitor ferritin and transferrin saturation over time 3
- Stability or decrease in levels makes iron overload disease unlikely
- Re-evaluate for secondary causes (alcohol, metabolic syndrome, inflammation)
The 2022 EASL guidelines 1 supersede the older 2005 ACP guidelines 5 and provide much more specific diagnostic thresholds and testing algorithms with strong consensus support.